Wedemeyer H - Search Results

1

Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients.

Ohlendorf V, Wübbolding M, Höner Zu Siederdissen C, Bremer B, Deterding K, Wedemeyer H, Cornberg M, Maasoumy B. Ohlendorf V, et al. Among authors: wedemeyer h. J Viral Hepat. 2024 Oct 19. doi: 10.1111/jvh.14026. Online ahead of print. J Viral Hepat. 2024. PMID: 39425534

2

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Among authors: wedemeyer h. Curr Gastroenterol Rep. 2002 Feb;4(1):23-30. doi: 10.1007/s11894-002-0034-y. Curr Gastroenterol Rep. 2002. PMID: 11825538 Review.

3

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

4

Long-term follow-up after successful interferon therapy of acute hepatitis C.

Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Wiegand J, et al. Among authors: wedemeyer h. Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091

5

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.

Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H. Cornberg M, et al. Among authors: wedemeyer h. J Hepatol. 2006 Feb;44(2):291-301. doi: 10.1016/j.jhep.2005.10.021. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16360972 Clinical Trial.

6

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group. Wiegand J, et al. Among authors: wedemeyer h. Hepatology. 2006 Feb;43(2):250-6. doi: 10.1002/hep.21043. Hepatology. 2006. PMID: 16440367 Clinical Trial.

7

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.

Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, Bantel H. Volkmann X, et al. Among authors: wedemeyer h. Hepatology. 2006 Jun;43(6):1311-6. doi: 10.1002/hep.21186. Hepatology. 2006. PMID: 16729308

8

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.

Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Böker KH, Tillmann HL, Manns MP, Wedemeyer H. Deterding K, et al. Among authors: wedemeyer h. J Hepatol. 2006 Dec;45(6):770-8. doi: 10.1016/j.jhep.2006.07.023. Epub 2006 Sep 22. J Hepatol. 2006. PMID: 17034895

9

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.

Meyer MF, Lehmann M, Cornberg M, Wiegand J, Manns MP, Klade C, Wedemeyer H. Meyer MF, et al. Among authors: wedemeyer h. Virol J. 2007 Jun 11;4:58. doi: 10.1186/1743-422X-4-58. Virol J. 2007. PMID: 17562015 Free PMC article.

10

Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

Wiegand J, Cornberg M, Aslan N, Schlaphoff V, Sarrazin C, Kubitschke A, Buggisch P, Ciner A, Jaeckel E, Manns MP, Wedemeyer H. Wiegand J, et al. Among authors: wedemeyer h. Antivir Ther. 2007;12(3):303-16. Antivir Ther. 2007. PMID: 17591020 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

833 results

Search Page

Filters